Search By Initial

Name Index A

• AZD-8055 (Catalog# : 123019, Cas# : 1009298-09-2)AZD-8055 is an inhibitor of the mammalian target of rapamycin (mTOR) with potential a
• Amuvatinib (Catalog# : 123016, Cas# : 850879-09-3)Amuvatinib is a potent and multi-targeted inhibitor of c-Kit, PDGFR and Flt3 with IC5
• AR-42 (Catalog# : 123009, Cas# : 935881-37-1)AR-42 is a novel, oral cancer therapy currently in early clinical development.
• A-966492 (Catalog# : 123006, Cas# : 934162-61-5)A-966492 is a novel and potent inhibitor of PARP1 and PARP2 with Ki of 1 nM and 1.5 n
• AMG 487 (Catalog# : 122942, Cas# : 473719-41-4)AMG 487 is a small molecule antagonist of the chemokine receptor CXCR3.
• Atosiban acetate (Catalog# : 122931, Cas# : 90779-69-4)Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/
• AST-1306 (Catalog# : 122926, Cas# : 897383-62-9)AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and
• AZD8186 (Catalog# : 122925, Cas# : 1627494-13-6)AZD8186 is an isoform-specific small-molecule PI3K inhibitor, potently inhibits PI3K
• AG-120 (Catalog# : 122906, Cas# : 1448346-63-1)AG-120 is an orally available inhibitor of isocitrate dehydrogenase type 1 (IDH1), wi
• AZD-5423 (Catalog# : 122902, Cas# : 1034148-04-3)Coming soon!
• A 83-01 (Catalog# : 122843, Cas# : 909910-43-6)A 83-01 is a selective inhibitor of TGF- type I receptor ALK5 kinase, type I activin/
• AM251 (Catalog# : 122842, Cas# : 183232-66-8)AM251 is a potent CB1 receptor antagonist (IC50 = 8 nM, Ki = 7.49 nM) that displays 3
• AZD2858 (Catalog# : 122838, Cas# : 486424-20-8)AZD2858 is a selective GSK-3 inhibitor with an IC50 of 68 nM, inhibits tau phosphoryl
• Adjudin (Catalog# : 122824, Cas# : 252025-52-8)Adjudin is a drug which is under development as a potential non-hormonal male contrac
• AdipoRon (Catalog# : 122822, Cas# : 924416-43-3)AdipoRon is a novel small-molecule AdipoR agonist; binds to both AdipoR1(Kd= 1.8 uM)
• Anamorelin (Catalog# : 122407, Cas# : 249921-19-5)Anamorelin is a synthetic orally active ghrelin receptor agonist which is under devel
• Atorvastatin sodium (Catalog# : 122303, Cas# : 134523-01-6)Atorvastatin has the potential to ameliorate arsenic-induced vascular dysfunction and
• Amrubicin (Catalog# : 122211, Cas# : 110267-81-7)Amrubicin is a novel anthracycline derivative for treatment of bladder carcinoma.
• AG 490 (Catalog# : 122210, Cas# : 134036-52-5)AG-490 is a tyrosine kinase inhibitor of JAK2, EGFR, and Neu that belongs to the fami
• APD597 (Catalog# : 121804, Cas# : 897732-93-3)APD597 is a potent and selective GPR119 agonist, which is potential useful for the tr
• AT-101 (Catalog# : 121434, Cas# : 90141-22-3)AT-101 is the orally bioavailable the R-(-) enantiomer of gossypol with potential ant
• 4-Aminobenzeneboronic Acid Hydrochloride (Catalog# : 120701, Cas# : 80460-73-7)Coming soon!
• Alendronate sodium trihydrate (Catalog# : 120409, Cas# : 121268-17-5)Coming soon!
• Ambroxol hydrochloride (Catalog# : 120408, Cas# : 23828-92-4)Coming soon!
• Actinomycin D (Catalog# : 120110, Cas# : 50-76-0)Actinomycin D is the most significant member of actinomycines, which are a class of p
• Altiratinib (Catalog# : 120104, Cas# : 1345847-93-9)Altiratinib is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden i
• AGI-5198 (Catalog# : 120103, Cas# : 1355326-35-0)AGI-5198 is a novel R132H-IDH1 inhibitor, identified through a high-throughput screen
• Acotiamide HCl (Catalog# : 120102, Cas# : 773092-05-0)Acotiamide is a drug approved in Japan for the treatment of postprandial fullness, up
• A66 (Catalog# : 120101, Cas# : 1166227-08-2)A66 is a potent and specific p110 inhibitor with IC50 of 32 nM, >100 fold selectiv
• AV-412 (Catalog# : 112101, Cas# : 451492-95-8)AV-412 is an EGFR/HER2 inhibitor that binds to and inhibits the epidermal growth fact